Leading the Charge
The Backbone of our Innovation
The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.
Roger A. Jeffs
Joined Dova Board: May 2017
Dr. Jeffs is the former President and Co-Chief Executive Officer of United Therapeutics Corporation, which he joined in 1998. During Dr. Jeffs’ career at United Therapeutics, he oversaw the company’s global clinical, commercial, manufacturing, regulatory, pharmacovigilance, and business development efforts. Prior to joining United Therapeutics, Dr. Jeffs served as the worldwide clinical leader of the Infectious Disease Program at Amgen, Inc. Prior to Amgen, he was a member of the clinical research team at Burroughs Wellcome & Company. He currently serves on the board of Axsome Therapeutics. Dr. Jeffs received his B.S. in Chemistry from Duke University and his Ph.D. in Pharmacology from the University of North Carolina.